U.S. Department of Health and Human Services
NATIONAL INSTITUTES OF HEALTH NIH News
National Center for Advancing Translational Sciences (NCATS) <
https://ncats.nih.gov/>
For Immediate Release: Monday, November 2, 2020
Contact: NCATS Communications Branch, 301-435-0888, <e-mail: ncatsinfo@xxxxxxxxxxxx>
MEDIA ADVISORY
NIH SUMMIT ON STATE OF SARS-COV-2 ANTIVIRAL THERAPEUTICS DEVELOPMENT
What
The National Institutes of Health is hosting the Virtual SARS-CoV-2 Antiviral Therapeutics Summit <
https://www.nih.gov/antiviralcov2summit> on November 6, 2020, to discuss progress and remaining challenges in developing antiviral treatments for COVID-19. Experts from academia, industry, NIH and other parts of the federal government will discuss such topics as SARS-CoV-2 targets for drug development and tools to test promising antiviral drug candidates. They also will identify unmet research needs, share lessons learned from other infectious diseases, and explore opportunities for public-private partnerships. The meeting is sponsored by NIH's National Center for Advancing Translational Sciences and National Institute of Allergy and Infectious Diseases.
Agenda <
https://web.cvent.com/event/ce4aab92-36ef-408b-bb7d-5f24f3886e7d/websitePage:4a9f1ae7-fd5e-40ea-a47b-8748de11f650?rp=00000000-0000-0000-0000-000000000000>
Who
Hosts and Opening Speakers:
-- Francis S. Collins, M.D., Ph.D., Director, National Institutes of Health
-- Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases
-- Christopher P. Austin, M.D., Director, National Center for Advancing Translational Sciences
Panel Moderators and Speakers:
-- Annaliesa Anderson, Ph.D., Vice President and Chief Scientific Officer, Bacterial Vaccines, Chief Scientific Officer, The Hospitals Business Unit, Pfizer
-- Kara Carter, Ph.D., Executive Vice President of Infectious Disease, Evotec
-- Tomas Cihlar, Ph.D., Vice President of Virology, Gilead Sciences
-- Kizzmekia Corbett, Ph.D., Research Fellow, Vaccine Research Center, National Institute of Allergy and Infectious Diseases
-- Mark Denison, M.D., Stahlman Professor of Pediatrics, Director of the Division of Pediatric Infectious Diseases, Vanderbilt University Medical Center
-- Daria Hazuda, Ph.D., Vice President of Infectious Disease and Vaccines, Chief Scientific Officer of the Exploratory Science Center, Merck & Co., Inc.
-- Pei-Yong Shi, Ph.D., John Sealy Distinguished Chair in Innovations in Molecular Biology, University of Texas Medical Branch
-- Richard Whitley, M.D., Distinguished Professor of Pediatrics, Vice Chairman of the Department of Pediatrics and Co-Division Director of Pediatric Infectious Diseases, University of Alabama at Birmingham
Hosts, Presenters and Panelists <
https://web.cvent.com/event/ce4aab92-36ef-408b-bb7d-5f24f3886e7d/websitePage:81b69b71-ce7e-47a0-9eb5-fae562c471f6?rp=00000000-0000-0000-0000-000000000000>
When
Friday, Nov. 6, 2020; 11 a.m. - 3:30 p.m. EST
Where
The meeting is virtual and can be viewed live or archived on NIH's videocast website <
https://videocast.nih.gov/>. Registration is not required.
Contact
Discussion questions may be submitted in advance via the meeting website <
https://www.nih.gov/antiviralcov2summit>. For media interested in interviewing NIH spokespeople involved in the summit, please contact ncatsinfo@xxxxxxxxxxxx.
About the National Center for Advancing Translational Sciences (NCATS): NCATS conducts and supports research on the science and operation of translation - the process by which interventions to improve health are developed and implemented - to allow more treatments to get to more patients more quickly. For more information about how NCATS helps shorten the journey from scientific observation to clinical intervention, visit <
https://ncats.nih.gov>.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit <www.nih.gov>.
NIH...Turning Discovery into Health -- Registered, U.S. Patent and Trademark Office
###
To subscribe (or unsubscribe) from NIH News Release mailings, go to
<
http://service.govdelivery.com/service/subscribe.html?code=USNIH_1>.
If you subscribed via the NIH LISTSERV, go to <
https://list.nih.gov/cgi-bin/wa.exe?A0=nihpress>.
